Neuro-Oncology

Top Story

‘Cancer-agnostic’ NTRK inhibitor approval ushers in paradigm of personalized genomics-guided therapeutics

‘Cancer-agnostic’ NTRK inhibitor approval ushers in paradigm of personalized genomics-guided therapeutics
HemOnc Today, January 10, 2019
Patrick C. Ma, MD, MSc
In the Journals PlusPerspective

US cancer deaths down 27% in 25 years, but socioeconomic gaps widening

January 8, 2019
The overall rate of cancer deaths in the U.S. has declined by 27% during the past 25 years, with approximately 2.6 million fewer cancer deaths reported between 1991 and…

UCLA neurosurgeon receives award

January 6, 2019
Linda M. Liau, MD, PhD, MBA, received the Abhijit Guha Award in recognition of her work treating brain tumors. The award — sponsored jointly by Society for…
Feature

NIH grant to fund study of fertility planning tool for cancer survivors

December 21, 2018
The NIH awarded a 5-year, $693,000 grant to The Feinstein Institute for Medical Research to develop and test a digital health platform to help young female cancer…
More Headlines »
CME CNE

Improving Colorectal Cancer Screening and Prevention: Advances in Polyp Detection and Resection

This activity is supported by an educational grant from Aries Pharmaceuticals, Inc.

Colorectal cancer (CRC) is the third most common type of cancer worldwide and the second deadliest form of cancer in…
More »
Video
Meeting News

VIDEO: Late health problems becoming less common in childhood cancer survivors

June 4, 2017
More »
CME ABIM MOC

Ace the Case: A 33-Year-Old Woman with a Mass in Her Right Breast

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the diagnosis and management of a breast mass in a…
More »